| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.42B | -0.9% |
| R&D Expense | $539.0M | +7.2% |
| SG&A Expense | $2.51B | -19.5% |
| Operating Income | $4.51B | +70.7% |
| Interest Expense | $302.0M | -5.3% |
| Pre-tax Income | $4.29B | +78.8% |
| Income Tax | $708.0M | +1.3% |
| Net Income | $3.58B | +110.7% |
| EPS (Basic) | $4.19 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.52B | +17.8% |
| Accounts Receivable | $2.83B | +17.9% |
| Inventory | $2.64B | +34.0% |
| Current Assets | $9.88B | -13.4% |
| Total Assets | $26.09B | -0.3% |
| Current Liabilities | $6.03B | -9.0% |
| Long-term Debt | $8.70B | -8.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.74B | -22.1% |
| Investing Cash Flow | $1.75B | +352.2% |
| Financing Cash Flow | -$2.93B | -87.6% |
| +118.2% |
| EPS (Diluted) | $4.10 | +119.3% |
| Total Liabilities |
| $18.01B |
| -5.6% |
| Stockholders' Equity | $8.08B | +13.8% |